Home and hospital: Merck-Ridgeback halt and advance COVID-19 study for different patient groups April 15, 2021 By Lee Landenberger No Comments Merck & Co. Inc. has shut down two COVID-19 therapy development studies while moving another into a phase III trial.Read More